Counterclaims Filed In HIV Treatment Patent Suit
ABLSA filed suit against AmeriPath in January in the U.S. District Court for the Eastern District of Texas, claiming that AmeriPath products, like its HIV-1 Phenoscript test, infringed on two of ABLSA’s patents.
HIV-1 Phenoscript is made by Specialty Laboratories, a clinical reference laboratory that recently merged with AmeriPath.
The European company claimed that its patents, U.S. Patent Numbers 6,081,786 and...
To view the full article, register now.